🚀 VC round data is live in beta, check it out!
SOTHEMA Valuation Multiples
Discover revenue and EBITDA valuation multiples for SOTHEMA and similar public comparables like Zenas BioPharma, Monte Rosa Therapeutics, Bio-Thera Solutions, MBX Biosciences and more.
SOTHEMA Overview
About SOTHEMA
SOTHEMA engages in representation, purchase and sale of pharmaceutical, chemical, health-related, biological, veterinary, plant-based, cosmetic and scented products. The company sells its products in Morocco and overseas.
Founded
1976
HQ
Employees
N/A
Website
Financials (FY)
EV
$1B
SOTHEMA Financials
SOTHEMA reported last fiscal year revenue of $312M and EBITDA of $66M.
In the same fiscal year, SOTHEMA generated $148M in gross profit, $66M in EBITDA, and $35M in net income.
SOTHEMA P&L
In the most recent fiscal year, SOTHEMA reported revenue of $312M and EBITDA of $66M.
SOTHEMA expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $312M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $148M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 47% | XXX | XXX | XXX |
| EBITDA | — | XXX | $66M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 21% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 20% | XXX | XXX | XXX |
| Net Profit | — | XXX | $35M | XXX | XXX | XXX |
| Net Margin | — | XXX | 11% | XXX | XXX | XXX |
| Net Debt | — | — | $57M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
SOTHEMA Stock Performance
SOTHEMA has current market cap of $1B, and enterprise value of $1B.
SOTHEMA's stock price is $196.53.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $1B | — | XXX | XXX | XXX | $4.85 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSOTHEMA Valuation Multiples
SOTHEMA trades at 4.6x EV/Revenue multiple, and 21.9x EV/EBITDA.
SOTHEMA Financial Valuation Multiples
As of March 29, 2026, SOTHEMA has market cap of $1B and EV of $1B.
Equity research analysts estimate SOTHEMA's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
SOTHEMA has a P/E ratio of 40.5x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 4.6x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 21.9x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 23.3x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 9.8x | XXX | XXX | XXX |
| P/E | — | XXX | 40.5x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 108.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified SOTHEMA Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
SOTHEMA Margins & Growth Rates
SOTHEMA's revenue in the last fiscal year grew by 13%.
SOTHEMA Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 13% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 21% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 28% | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 2% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 0% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 0% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 27% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
SOTHEMA Public Comps
See public comps and valuation multiples for other Biopharmaceuticals and Wholesale Distribution comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Zenas BioPharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Monte Rosa Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Bio-Thera Solutions | XXX | XXX | XXX | XXX | XXX | XXX |
| MBX Biosciences | XXX | XXX | XXX | XXX | XXX | XXX |
| Oscotec | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
SOTHEMA M&A Activity
SOTHEMA acquired XXX companies to date.
Last acquisition by SOTHEMA was on XXXXXXXX, XXXXX. SOTHEMA acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by SOTHEMA
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialSOTHEMA Investment Activity
SOTHEMA invested in XXX companies to date.
SOTHEMA made its latest investment on XXXXXXXX, XXXXX. SOTHEMA invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by SOTHEMA
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout SOTHEMA
| When was SOTHEMA founded? | SOTHEMA was founded in 1976. |
| Where is SOTHEMA headquartered? | SOTHEMA is headquartered in Morocco. |
| Is SOTHEMA publicly listed? | Yes, SOTHEMA is a public company listed on Casablanca Stock Exchange. |
| What is the stock symbol of SOTHEMA? | SOTHEMA trades under SOT ticker. |
| When did SOTHEMA go public? | SOTHEMA went public in 2005. |
| Who are competitors of SOTHEMA? | SOTHEMA main competitors are Zenas BioPharma, Monte Rosa Therapeutics, Bio-Thera Solutions, MBX Biosciences. |
| What is the current market cap of SOTHEMA? | SOTHEMA's current market cap is $1B. |
| What is the current revenue of SOTHEMA? | SOTHEMA's last fiscal year revenue is $312M. |
| What is the current EV/Revenue multiple of SOTHEMA? | Current revenue multiple of SOTHEMA is 4.6x. |
| Is SOTHEMA profitable? | No, SOTHEMA is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.